Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-3
|
pubmed:dateCreated |
1996-3-1
|
pubmed:abstractText |
Protection against the development of nephrotoxicity following the administration of cadmium-metallothionein (CdMT) at a dose of 0.4 mg Cd per kg body weights was studied in streptozotocin (STZ)-induced diabetic rats. Six groups of Wistar male rats were used (Groups A and B, Groups A1 and C, and Groups A2 and D were injected intraperitoneally with STZ at doses of 0, 50 and 100 mg/kg, respectively, and then 6 days later, Groups B, C and D were injected subcutaneously with CdMT). Proteinuria, albuminuria and transferrinuria were observed after the administration of CdMT, and a dose-related decrease following the increased STZ dose was seen in Groups B, C and D. The concentrations of metallothionein (MT) and zinc (Zn) in liver and kidney were dose-dependently increased in Groups B, C and D. Induction of increased MT synthesis in liver and kidney as the result of the STZ treatment was observed in this study. In particular, a remarkable increase in liver MT concentration was induced by STZ, and transport to the kidney of MT synthesized in liver may perhaps explain the protection against cadmium nephrotoxicity in STZ-induced diabetic rats.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cadmium,
http://linkedlifedata.com/resource/pubmed/chemical/Metallothionein,
http://linkedlifedata.com/resource/pubmed/chemical/Metals,
http://linkedlifedata.com/resource/pubmed/chemical/Streptozocin,
http://linkedlifedata.com/resource/pubmed/chemical/Transferrin,
http://linkedlifedata.com/resource/pubmed/chemical/cadmium-binding protein
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0300-483X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
8
|
pubmed:volume |
106
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
55-63
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8571402-Animals,
pubmed-meshheading:8571402-Cadmium,
pubmed-meshheading:8571402-Chromatography, Gel,
pubmed-meshheading:8571402-Cytosol,
pubmed-meshheading:8571402-Diabetes Mellitus, Experimental,
pubmed-meshheading:8571402-Kidney,
pubmed-meshheading:8571402-Kidney Diseases,
pubmed-meshheading:8571402-Liver,
pubmed-meshheading:8571402-Male,
pubmed-meshheading:8571402-Metallothionein,
pubmed-meshheading:8571402-Metals,
pubmed-meshheading:8571402-Proteinuria,
pubmed-meshheading:8571402-Rats,
pubmed-meshheading:8571402-Rats, Wistar,
pubmed-meshheading:8571402-Streptozocin,
pubmed-meshheading:8571402-Transferrin,
pubmed-meshheading:8571402-Urination
|
pubmed:year |
1996
|
pubmed:articleTitle |
Protection against cadmium-metallothionein nephrotoxicity in streptozotocin-induced diabetic rats: role of increased metallothionein synthesis induced by streptozotocin.
|
pubmed:affiliation |
Department of Environmental Medicine, University of Umeå, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|